Datametrex AI Limited DM
This picture changes. Follow Datametrex AI Limited free — email when the signal or risk changes + a Sunday weekly brief.
Follow Datametrex AI Limited freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Full analysis: 6 Apr 2026
Latest news check: 29 Jul 2026
General analysis — not personal advice.
SELL
8/10
Confidence
Avoid new buys; if already holding, consider reducing ahead of 2026-04-20 and reassess after clearer cash-flow evidence.
Unchanged high risk from weak cash position, low liquidity and absence of new catalysts supports the reduce signal.
Market sentiment
6/10
↑
Trend: Improving
Sentiment has improved modestly as the new contracts imply higher margins and patent licensing adds a new potential revenue path, but the market still appears to be waiting for proof of durable cash flow and clarity on financing needs.
Price context
The stock trades at 0.035 CAD, exactly at the 52-week low, reflecting persistent lack of buying interest and weak market confidence. Any reversal requires concrete licensing revenues or orders.
Risk assessment
9/10
Dilution:
High
Short runway and repeated financings
Jurisdiction:
Low
Operates in Canada/US/South Korea
Execution:
High
Repeated pivots and weak profitability
Recent changes
- ▲ Sentiment is slightly less negative and shifts from declining to stable, though caution remains around cash flow and dilution.
About the company
Datametrex AI Limited is a Canadian micro-cap combining AI healthcare software (EMR), data-center/infrastructure delivery, and payments patent licensing via Paymetrex. The company is in a restructuring/growth phase and remains unprofitable, with elevated dilution and execution risk. Price action and attention are driven mainly by small orders/licensing headlines rather than stable cash flows.
Sector:
AI and IT services (healthcare, data centers, payments IP)
Type:
Tech
Next report
31 Aug 2026
Q1
Catalysts
Unknown
QuantIP patent licensing
Medium
Horizon:
Bull case
Licensing deals via QuantIP could create a new revenue stream and trigger re-rating.
Bear case
Large share volume may become tradable and ongoing losses raise the risk of new equity issuance.
Signal rationale (informational)
Unchanged high risk from weak cash position, low liquidity and absence of new catalysts supports the reduce signal.
Recent news
- No new press releases or company-specific events have been published after 2 July 2026. AGM scheduled for 28 August 2026 and Q1 report expected by end of August.
Price & valuation
Last close
CAD 0.03
1 week
-14.3 %
3 months
-40.0 %
12 months
-62.5 %
From 52w high
-76.9 %
From 52w low
0.0 %
Exchange
TSX-V
Type
Technology
Sector
AI and IT services (healthcare, data centers, payments IP)
This picture changes. Follow Datametrex AI Limited free — email when the signal or risk changes + a Sunday weekly brief.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.